Vardenafil (levitra) for erectile dysfunction

Med Lett Drugs Ther. 2003 Sep 29;45(1166):77-8.
No abstract available

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Clinical Trials as Topic
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Diabetes Complications
  • Diabetic Angiopathies / complications
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Enzyme Inhibitors / pharmacokinetics
  • Enzyme Inhibitors / therapeutic use
  • Erectile Dysfunction / drug therapy*
  • Erectile Dysfunction / etiology
  • Fees, Pharmaceutical
  • Humans
  • Imidazoles / pharmacokinetics
  • Imidazoles / therapeutic use*
  • Male
  • Phosphoric Diester Hydrolases / drug effects
  • Piperazines / pharmacokinetics
  • Piperazines / therapeutic use*
  • Prostatectomy / adverse effects
  • Sulfones
  • Triazines
  • Vardenafil Dihydrochloride

Substances

  • Enzyme Inhibitors
  • Imidazoles
  • Piperazines
  • Sulfones
  • Triazines
  • Vardenafil Dihydrochloride
  • Phosphoric Diester Hydrolases
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • PDE5A protein, human